Background rates of 41 adverse events of special interest for COVID-19 vaccines in 10 European healthcare databases - an ACCESS cohort study

BACKGROUND: In May 2020, the ACCESS (The vACCine covid-19 monitoring readinESS) project was launched to prepare real-world monitoring of COVID-19 vaccines. Within this project, this study aimed to generate background incidence rates of 41 adverse events of special interest (AESI) to contextualize po...

Descripción completa

Detalles Bibliográficos
Autores principales: Willame, C, Dodd, C, Durán, CE, Elbers, RJHJ, Gini, R, Bartolini, C, Paoletti, O, Wang, L, Ehrenstein, V, Kahlert, J, Haug, U, Schink, T, Diez-Domingo, J, Mira-Iglesias, A, Carreras, JJ, Vergara-Hernández, C, Giaquinto, C, Barbieri, E, Stona, L, Huerta, C, Martín-Pérez, M, García-Poza, P, de Burgos, A, Martínez-González, M, Bryant, V, Villalobos, F, Pallejà-Millán, M, Aragón, M, Souverein, P, Thurin, NH, Weibel, D, Klungel, OH, Sturkenboom, MCJM
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Author(s). Published by Elsevier Ltd. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678835/
https://www.ncbi.nlm.nih.gov/pubmed/36446653
http://dx.doi.org/10.1016/j.vaccine.2022.11.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9678835/
https://www.ncbi.nlm.nih.gov/pubmed/36446653
http://dx.doi.org/10.1016/j.vaccine.2022.11.031

Ejemplares similares